insights_auto
为什么 AGIO 下跌了 4.03%?
深入探索chevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$27.60
arrow_downward
-4.03%(-1.16) 1 天
US$27.60
0.00% (0.00)
bedtime盘后交易
休市: 11月20日, GMT-5 16:00:00 · USD
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 AGIO 生成关键数据洞见…
开盘价
US$28.01
最高价
US$29.14
最低价
US$27.43
市值
16.51亿
平均成交量
112.76万
成交量
77.62万
52 周最高价
US$44.07
52 周最低价
US$23.02
每股收益
-US$6.32
Beta 版
0.66
流通股数
5981.00万
员工人数
540
开盘价
US$28.01
最高价
US$29.14
最低价
US$27.43
市值
16.51亿
平均成交量
112.76万
成交量
77.62万
52 周最高价
US$44.07
52 周最低价
US$23.02
每股收益
-US$6.32
Beta 版
0.66
流通股数
5981.00万
员工人数
540
新闻报道
来自网络来源和新闻合作伙伴
The Motley Fool
·
49分钟前
If the S&P 500 Drops by 20%, I'm Buying These 3 ETFs Without Hesitation
Traders Union
·
1小时前
Seventeen of the twenty largest S&P 500 drops began below the 200-day moving average, Ryan Detrick notes
24/7 Wall St.
·
47分钟前
Jim Cramer Says the Market “Sliced Right Through” His S&P 500 Target
资料
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Agios Pharmaceuticals Inc简介